Emergency personnel transport a 24-year-old female to the resuscitation bay following accidental ingestion of a walnut-containing dessert at a local bakery. Symptom onset was precipitous, featuring diffuse urticaria, marked facial angioedema, and severe respiratory distress within 10 minutes of exposure. Upon arrival, the patient exhibits gasping respirations. Vital signs include a heart rate of 132/min, a blood pressure of 82/50 mm Hg, and an oxygen saturation of 88% on ambient air. Physical assessment confirms inspiratory stridor and widespread expiratory wheezing. Arrange the following pharmacologic interventions in the most appropriate chronological sequence for this patient's acute stabilization and management.
- 1Intramuscular epinephrine
- 2Nebulized albuterol
- 3Intravenous diphenhydramine
- 4Intravenous methylprednisolone
Answer
The correct sequence prioritizes immediate life-saving therapy (epinephrine), followed by targeted symptom relief for the lower airway (albuterol), then cutaneous symptom management (diphenhydramine), and finally delayed-onset medications to prevent recurrence (methylprednisolone).
The management of anaphylaxis follows a strict clinical hierarchy. Intramuscular epinephrine is the definitive first-line treatment that must be given immediately to stabilize the airway and blood pressure. Nebulized albuterol is administered next for any remaining lower airway bronchospasm. Diphenhydramine is an antihistamine that only addresses cutaneous symptoms (hives and itching) and does not treat shock, making it a lower priority. Finally, systemic corticosteroids like methylprednisolone take several hours to reach peak efficacy and are used to prevent biphasic reactions, placing them last in the acute stabilization sequence.
Step-by-Step Solution
Key Concept
The correct prioritization of pharmacologic interventions in anaphylaxis mandates that immediate life-saving agents are administered prior to slower-acting adjunctive therapies.